Trouble du déficit d'attention/hyperactivité de l'adulte
(Atttention Deficit/Hyperactivity Disorder)
-
Functional and psychosocial impairment in adults with
undiagnosed ADHD.
Able SL,
Johnston JA,
Adler LA,
Swindle RW.
US Outcomes Research, Lilly Research Laboratories,
Indianapolis, IN, USA.
Background. Identify a group of adults with 'undiagnosed'
attention deficit hyperactivity disorder (ADHD) and compare
their personal and family medical histories, psychosocial
profiles, functional impairment and quality of life with
non-ADHD controls. Additionally, compare adults with
undiagnosed and diagnosed ADHD to investigate possible
reasons why the undiagnosed avoid clinical detection.Method.
ICD-9 codes for ADHD in administrative claims records and
responses to a telephone-administered adult ADHD screener [the
Adult ADHD Self-Report Scale (ASRS)] were used to classify
approximately 21000 members of two large managed health-care
plans as 'undiagnosed' (no coded diagnosis; ASRS positive)
or 'non-ADHD' controls (no coded diagnosis; ASRS negative).
Patients identified as 'undiagnosed' ADHD were compared with
samples of non-ADHD controls and 'diagnosed' ADHD patients
(ICD-9 coded ADHD diagnoses) on the basis of demographics,
socio-economic status, past and present mental health
conditions, and self-reported functional and psychosocial
impairment and quality of life.Results. A total of 752 'undiagnosed'
ADHD subjects, 199 'non-ADHD' controls and 198 'diagnosed'
ADHD subjects completed a telephone interview. Overall, the
'undiagnosed' ADHD cohort demonstrated higher rates of co-morbid
illness and greater functional impairment than 'non-ADHD'
controls, including significantly higher rates of current
depression, and problem drinking, lower educational
attainment, and greater emotional and interpersonal
difficulties. 'Undiagnosed' ADHD subjects reported a
different racial composition and lower educational
attainment than 'diagnosed' ADHD subjects.Conclusion.
Individuals with 'undiagnosed' ADHD manifest significantly
greater functional and psychosocial impairment than those
screening negative for the disorder, suggesting that ADHD
poses a serious burden to adults even when clinically
unrecognized.
PMID: 16938146 [PubMed - as supplied by publisher]
|
| 2:
Arch Clin Neuropsychol. 2005 Mar;20(2):249-69. |
|
Attention Deficit Hyperactivity Disorder: manifestation in adulthood.
Riccio CA, Wolfe M, Davis B, Romine C, George C, Lee D.
Department of Educational Psychology, Texas A & M University, TAMU MS4225,
College Station, TX 77843-4225, USA. criccio@tamu.edu
The purpose of the current study was to investigate the manifestation of ADHD in
adults using a combination of structured clinical interview, behavioral
self-report, and a range of neuropsychological measures. Symptom criteria that
are endorsed by adults with ADHD as compared to non-diagnosed adults and an
adult sample with other clinical disorders tend to reflect problems with
follow-through, forgetting, organization, and losing things. Notably, adults in
the No Diagnosis group endorsed a higher frequency of symptoms than base rates
reported elsewhere. Related to sense of time, adults with ADHD endorsed problems
with meeting deadlines, not completing tasks, not planning ahead, and having a
poorer sense of time significantly more frequently than adults in either the
No-Diagnosis or Other Clinical Disorder group. Results highlighted the need for
further research specific to the manifestation of ADHD in adulthood and the
development of diagnostic criteria that take into account the differences in
development as well as age-related differences in contextual demands.
PMID: 15708734 [PubMed - indexed for MEDLINE]
| 3 :
Can Fam Physician. 2005 Jan;51:53-9. |
|
Attention deficit disorder in adults. Management in primary care.
Kates N.
Department of Psychiatry and Behavioural Neurosciences, McMaster University,
Hamilton, Ont.
OBJECTIVE: To review the ways attention deficit disorder (ADD) presents in
adults in primary care and to suggest treatment approaches. SOURCES OF
INFORMATION: PsycINFO, PubMed, and Academic Search Elite databases were
searched. Level I evidence supports the effectiveness of stimulants for
treating ADD in adults, and mixed evidence (levels I and II) supports the
effectiveness of antidepressants. MAIN MESSAGE: Attention deficit disorder is
a prevalent but often unrecognized disorder in adults. The diagnosis, which
must include onset of symptoms before age 7, is often missed. This could be
because family physicians are not always familiar with the presentation in
adults, because it frequently presents with comorbid problems, or because
specific questions are not asked to elicit the diagnosis. Diagnosis is based
on clinical assessment often assisted by self-rating scales. Management
includes support and education, helping patients develop additional structure
in their lives and make necessary behavioural changes, enhancing self-esteem,
supporting and educating families, and prescribing medication. Medication
choices include stimulants and antidepressants; medication can benefit up to
60% of people with ADD. CONCLUSION: It is crucial for primary care physicians
to identify ADD in adults and to initiate treatment or referral. Several
simple interventions can be employed.
PMID: 15732222 [PubMed - indexed for MEDLINE]
Comment in:
Can Fam Physician. 2005 Jan;51:16, 20-1.
4- Entrevue Medscape, mai 2004
Treatment for Adult ADHD: A Newsmaker Interview With
Timothy Wilens, M. par Martin Korn, MD
|
5:
J Clin Psychiatry 2004; 65 (suppl 3:27-37) |
|
A Guide to The Treatment of Adults With ADHD
Margaret D. Weiss, M.D., Ph.d., and Jacqueline R.
Weiss, M. D.
While child and adolescent physicians are
familiar with the treatment of attention-deficit/hyperactivity disorder (ADHD),
many adult physicians have little experience with the disorder. It is difficult
to develop clinical skills in the management of residual adult manifestations of
developmental disorders without clinical experience
with their presentation in childhood. Adult patients
are increasingly seeking treatment for the symptoms of ADHD, and physicians need
practice guidelines. Adult ADHD often presents differently from childhood
ADHD. Because adult ADHD can be comorbid with other disorders and has symptoms
similar to those of other disorders, it is important to understand differential
diagnoses. Physicians should work with patients to provide feedback about their
symptoms, to educate them about ADHD, anb to set treatment goals.
Treatment for
ADHD in adults should include a medication trial, restructuring of patient's
environment to make it more compatible with the sypmtoms of ADHD, and ongoing
supportive management to address any residual impairment and to facilitate
functional and developmental improvements.
Commentaires: les
auteurs conservent toujours une perspective clinique, faisant un lien constant entre enfance et âge adulte,
comme leur expérience le permet. Ils ajoutent même de nouveaux critères d'observation non-inclus au DSM IV, comme la procrastination, la surréaction à la frustration,
la sous-motivation, l'insomnie et la mauvaise organisation temporelle.
La psychiatrie de l'adulte se doit d'être prudente et vigilante avant de poser
des diagnostics lourds, comme la maladie bipolaire ou la dépression unipolaire, le
trouble de personnalité limite (borderline), sans prendre en compte
toutes les variantes du TDA/H qui, chez l'adulte, n'ont pas eu tous les égards à
ce jour.
CJ
Disponible librairie McGill, dans le
Journal of Clinical Psychiatry
| 6:
CMAJ • March 18, 2003; 168 (6) |
|
|
Assessment and management of
attention-deficit hyperactivity disorder in adults
Margaret
Weiss
and Candice Murray
(Dr.
Weiss
is with the Division of Child Psychiatry and Ms. Murray is with the Department
of Psychology, University of British Columbia, Vancouver, BC.)
Correspondence to:
Dr. Margaret
Weiss,
Rm. B430, Children's and Women's Health Centre of British Columbia, 4500 Oak
St., Vancouver BC V6H 3N1; fax 604 875-2468;
mweiss@cw.bc.ca
Attention-deficit hyperactivity disorder (ADHD) is estimated
to
affect 2%–6% of adults. The symptoms in adults with ADHD mirror those
in children with the disorder and are associated with significant
educational, occupational and interpersonal difficulties.
Double-blind, placebo-controlled trials have established that adult
ADHD is responsive to stimulant medication treatment. New medications
and psychotherapeutic approaches are being developed in an effort to
achieve optimal treatment effects in this population. We review the
available literature and provide an approach to the assessment and
management of ADHD in adults.
© 2003
Canadian Medical Association
or its licensors
Texte disponible librairie McGill, dans le
Canadian Association Medical Journal
|
7: Biol Psychiatry. 2004 Apr 1;55(7):692-700.
|
|
Gender effects on Attention-Deficit/Hyperactivity disorder in adults, revisited
Biederman J, Faraone SV, Monuteaux MC, Bober M, Cadogen E.
Pediatric Psychopharmacology Unit of the Psychiatry Department (JB, SVF, MCM,
MB, EC), Massachusetts General Hospital, Boston, Massachusetts, USA.
BACKGROUND: This study reexamined gender differences in a large sample of adults
with attention-deficit/hyperactivity disorder (ADHD). METHODS: We assessed the
effects of ADHD, gender, and their interaction on rates of psychiatric
comorbidity and cognitive functioning in 219 adults with ADHD who were referred
to an outpatient psychiatric clinic over the last 7 years compared with 215
control subjects group-matched to control subjects on age and gender, and
ascertained from ongoing family genetic case control adults with ADHD. RESULTS:
There was no evidence that gender moderated the association between ADHD and
other psychiatric disorders. Attention-deficit/hyperactivity disorder was
associated with cognitive deficits and higher rates of major depression, anxiety,
substance use disorders, and antisocial personality disorder.
CONCLUSIONS: Attention-deficit/hyperactivity disorder in adults is associated with
psychiatric and cognitive impairment in both genders. These results bear
striking similarities to findings reported in pediatric samples, supporting the
validity of ADHD and stressing the importance of identifying and treating the
disorder in adulthood.
PMID: 15038997 [PubMed - in process]
Texte disponible librairie McGill, dans
Biological psychiatry
| 8: JAMA. 2004 Aug 4;292(5):619-23. |
|
Attention-deficit/hyperactivity disorder in adults.
Wilens TE, Faraone SV, Biederman J.
Clinical Research Program in Pediatric Psychopharmacology, Massachusetts General
Hospital and Harvard Medical School, Boston, Mass 02114-3139, USA. twilens@partners.org
PMID: 15292088 [PubMed - in process
commentaire:
article excellent et disponible sur
JAMA.
9: J Clin Psychiatry. 2004
Oct;65(10):1301-13.
A clinical perspective of attention-deficit/hyperactivity disorder into
adulthood.
Wilens TE, Dodson W.
From the Department of Psychiatry, Harvard Medical School, Boston,
Massachusetts (Dr. Wilens), and the Attention Disorders Treatment Center,
Denver, Colorado (Dr. Dodson).
OBJECTIVE: Attention-deficit/hyperactivity disorder (ADHD) is a common
psychiatric disorder that affects all age groups. Recent data on the clinical
presentation, comorbidity, neurobiology, and treatment are reviewed. METHOD:
Using the search term ADHD, a selective PubMed review of the clinical
literature was undertaken to evaluate recent data relevant to ADHD with
attention to a life span perspective of the disorder. RESULTS: A growing
literature indicates that ADHD is more persistent than previously thought and
has a developmental variability in its presentation. The disorder impairs
academic, social, and occupational functioning and is often associated with
comorbidity, including cigarette smoking and substance abuse. Considerable
evidence suggests that the disorder has a strong genetic component and a
biological underpinning; the pathophysiology includes dysfunction in both
noradrenergic and dopaminergic systems. Both psychosocial therapy and
pharmacotherapy have been shown effective in the treatment of the disorder
throughout the life span. The therapeutic effectiveness of pharmacologic
agents in the treatment of ADHD has been attributed to noradrenergic and/or
dopaminergic effects.
CONCLUSION: ADHD is associated with impairment and
comorbidity throughout the life span. Growing evidence suggests the importance
of short- and long-term management of the disorder. While the long-term
treatment of ADHD is expected to lessen the individual's impairment, the
outcome for adults who have received treatment since childhood requires
further study.
PMID: 15491232 [PubMed - in process]
Texte disponible librairie McGill
10:
Am J Psychiatry. 2004 Nov;161(11):1948-56.
Diagnostic controversies in adult attention deficit hyperactivity disorder.
McGough JJ, Barkley RA.
Suite 1414, 300 UCLA Medical Plaza, Los Angeles, CA 90095. jmcgough@mednet.ucla.edu.
OBJECTIVE: While it is increasingly recognized that attention deficit
hyperactivity disorder (ADHD) persists into adulthood, there is no consensus
on diagnostic criteria for adult ADHD. In this article the authors describe
and contrast competing approaches for diagnosis of adult ADHD used in
clinical and research practice. METHOD: The authors review the Wender Utah
criteria, DSM criteria, and laboratory assessment strategies for adult ADHD.
Advantages and disadvantages of each approach are described, and
recommendations are made as a basis for clinical assessment and future
research. RESULTS: Both the Wender Utah criteria and DSM-based approaches
identify significantly impaired ADHD adults with neurocognitive, biological,
and treatment response patterns similar to pediatric ADHD patients. The
Wender Utah criteria established the need for retrospective childhood
diagnosis and recognize developmental differences in adult symptom
expression. The Wender Utah criteria fail to identify patients with
predominately inattentive symptoms, exclude some patients with significant
comorbid psychopathology, and diverge significantly from the DSM conception
of ADHD. The DSM criteria have never been validated in adults, do not
include developmentally appropriate symptoms and thresholds for adults, and
fail to identify some significantly impaired adults who are likely to
benefit from treatment. There are insufficient scientific data to justify
use of laboratory assessment measures, including neuropsychological tests
and brain imaging, in diagnosing adult ADHD.
CONCLUSIONS: Adult ADHD remains
a clinical diagnosis. Clinicians should be flexible in application of the
current ADHD criteria to adults. Additional research is required to validate
adult diagnostic criteria.
PMID: 15514392 [PubMed - in process]
Disponible
http://ajp.psychiatryonline.org/cgi/content/full/161/11/1948
| 10: MMW
Fortschr Med. 2004 Aug 19;146(33-34):31-4. |
|
[Adult attention deficit/hyperactivity disorder][Article in German]
Laufkotter R, Eichhammer P, Hajak G.
Klinik und Poliklinik fur Psychiatrie und Psychotherapie der Universitat
Regensburg. rainer.laufkoetter@medbo.de
ADHD (attention deficit/hyperactivity disorder) in adults is a more complex
pathological condition than ADHD seen in children and adolescents. The number of
reports of impaired self-regulation are on the increase. Psychiatric comorbities
are being found ever more frequently, and negative life experiences are coloring
the clinical presentation to an ever greater extent. Therapeutic strategies
involving the use of stimulants and antidepressants are often needed to pave the
way for individual and group psychotherapy.
Despite the fact that it is
currently considered to be "fashionable", the diagnosis of ADHD is a clinically
relevant and persisting psychological disorder.
PMID: 15526623 [PubMed - in process]
| 11:
Psychol Med.
2005 Jun;35(6):807-16. |
|
Stopping and changing in adults with ADHD.
Bekker EM,
Overtoom CC,
Kenemans JL,
Kooij JJ,
De Noord I,
Buitelaar JK,
Verbaten MN.
Department of Psychopharmacology, Utrecht University, The Netherlands. E.M.Bekker@pharm.uu.nl
BACKGROUND: A lack of inhibitory control has been suggested to be the core
deficit in children with attention deficit hyperactivity disorder (ADHD). This
means that a primary deficit in behavioral inhibition mediates a cascade of
secondary deficits in other executive functions, such as arousal regulation.
Clinical observations have revealed that with increasing age symptoms of
hyperactivity and impulsivity decline at a higher rate than those of
inattention. This might imply that a deficit in attention rather than a lack of
inhibitory control is the major feature in adult ADHD. METHOD: To study whether
an attentional or inhibitory deficit predominates, the stop-signal task and the
stop-change task were presented to 24 adults with ADHD combined subtype and 24
controls. RESULTS: Relative to controls, the stop-signal reaction time (SSRT)
was significantly more prolonged than the go-stimulus reaction time (RT) in
patients with ADHD. This disproportionate elongation of the SSRT was comparable
across tasks, even though the stop-change task exerted more complex (or at least
different) demands on the inhibitory system than the stop-signal task. ADHD
patients had a higher proportion of choice errors, possibly reflecting more
premature responses. Specifically in the stop-change task, patients had more
variable choice responses and made more inappropriate change responses, which
may also reflect enhanced impulsivity. CONCLUSIONS: The results support a core
deficit in behavioral inhibition in adults with ADHD. We further suggest that
there is more evidence for a critical role of deficient inhibitory control in
adults than in children with ADHD.
PMID: 15997601 [PubMed - in process]